394 related articles for article (PubMed ID: 17310134)
1. Survival of AML patients receiving HLA-matched sibling donor allogeneic bone marrow transplantation correlates with HLA-Cw ligand groups for killer immunoglobulin-like receptors.
Sobecks RM; Ball EJ; Maciejewski JP; Rybicki LA; Brown S; Kalaycio M; Pohlman B; Andresen S; Theil KS; Dean R; Bolwell BJ
Bone Marrow Transplant; 2007 Apr; 39(7):417-24. PubMed ID: 17310134
[TBL] [Abstract][Full Text] [Related]
2. Status of donor-recipient HLA class I ligands and not the KIR genotype is predictive for the outcome of unrelated hematopoietic stem cell transplantation in beta-thalassemia patients.
La Nasa G; Littera R; Locatelli F; Giardini C; Ventrella A; Mulargia M; Vacca A; Orrù N; Orrù S; Piras E; Giustolisi G; Lisini D; Nesci S; Caocci G; Carcassi C
Biol Blood Marrow Transplant; 2007 Nov; 13(11):1358-68. PubMed ID: 17950922
[TBL] [Abstract][Full Text] [Related]
3. The role of missing killer cell immunoglobulin-like receptor ligands in T cell replete peripheral blood stem cell transplantation from HLA-identical siblings.
Clausen J; Kircher B; Auberger J; Schumacher P; Ulmer H; Hetzenauer G; Wolf D; Gastl G; Nachbaur D
Biol Blood Marrow Transplant; 2010 Feb; 16(2):273-80. PubMed ID: 19857587
[TBL] [Abstract][Full Text] [Related]
4. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
[TBL] [Abstract][Full Text] [Related]
5. KIR ligands and prediction of relapse after unrelated donor hematopoietic cell transplantation for hematologic malignancy.
Hsu KC; Gooley T; Malkki M; Pinto-Agnello C; Dupont B; Bignon JD; Bornhäuser M; Christiansen F; Gratwohl A; Morishima Y; Oudshoorn M; Ringden O; van Rood JJ; Petersdorf E;
Biol Blood Marrow Transplant; 2006 Aug; 12(8):828-36. PubMed ID: 16864053
[TBL] [Abstract][Full Text] [Related]
6. Effects of HLA allele and killer immunoglobulin-like receptor ligand matching on clinical outcome in leukemia patients undergoing transplantation with T-cell-replete marrow from an unrelated donor.
Morishima Y; Yabe T; Matsuo K; Kashiwase K; Inoko H; Saji H; Yamamoto K; Maruya E; Akatsuka Y; Onizuka M; Sakamaki H; Sao H; Ogawa S; Kato S; Juji T; Sasazuki T; Kodera Y;
Biol Blood Marrow Transplant; 2007 Mar; 13(3):315-28. PubMed ID: 17317585
[TBL] [Abstract][Full Text] [Related]
7. Natural killer cell HLA-C epitopes and killer cell immunoglobulin-like receptors both influence outcome of mismatched unrelated donor bone marrow transplants.
De Santis D; Bishara A; Witt CS; Nagler A; Brautbar C; Slavin S; Christiansen FT
Tissue Antigens; 2005 Jun; 65(6):519-28. PubMed ID: 15896199
[TBL] [Abstract][Full Text] [Related]
8. The impact of recipient HLA-Cw and donor killer immunoglobulin-like receptor genotyping on the outcome of patients receiving HLA-matched sibling donor hematopoietic stem cell transplantation for myeloid malignancies.
Wang H; He Y; Zhai WJ; Wang M; Zhou Z; Zhao YX; Feng SZ; Han MZ
Swiss Med Wkly; 2013; 143():w13717. PubMed ID: 23299929
[TBL] [Abstract][Full Text] [Related]
9. KIR2DS5 is associated with leukemia free survival after HLA identical stem cell transplantation in chronic myeloid leukemia patients.
van der Meer A; Schaap NP; Schattenberg AV; van Cranenbroek B; Tijssen HJ; Joosten I
Mol Immunol; 2008 Aug; 45(13):3631-8. PubMed ID: 18555529
[TBL] [Abstract][Full Text] [Related]
10. HLA-C matching and liver transplants: donor-recipient genotypes influence early outcome and CD8+KIR2D+ T-cells recuperation.
López-Alvarez MR; Moya-Quiles MR; Minguela A; Gil J; Miras M; Campillo JA; Díaz-Alderete MA; García-Alonso AM; Sánchez-Bueno F; Vicario JL; Muro M; Alvarez-López MR
Transplantation; 2009 Aug; 88(3 Suppl):S54-61. PubMed ID: 19667963
[TBL] [Abstract][Full Text] [Related]
11. Prognosis after unmanipulated HLA-haploidentical blood and marrow transplantation is correlated to the numbers of KIR ligands in recipients.
Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
Eur J Haematol; 2007 Apr; 78(4):338-46. PubMed ID: 17378893
[TBL] [Abstract][Full Text] [Related]
12. Hematopoietic stem cell transplantation: killer immunoglobulin-like receptor component.
Hsu KC; Pinto-Agnello C; Gooley T; Malkki M; Dupont B; Petersdorf EW
Tissue Antigens; 2007 Apr; 69 Suppl 1():42-5. PubMed ID: 17445161
[TBL] [Abstract][Full Text] [Related]
13. [Study on the behavior of NK cell KIRs of donor/recipient pairs in HLA matched unrelated allo-HSCT].
Bao XJ; He J; Chen ZX; Wu DP; Yao L; Yuan XN; Cen JN; Qiu QC; Di WY; Zhang H; Zhang J; Zhou XH; Xu HX
Zhonghua Xue Ye Xue Za Zhi; 2007 Aug; 28(8):510-3. PubMed ID: 18078124
[TBL] [Abstract][Full Text] [Related]
14. Donor killer immunoglobulin-like receptor (KIR) genotype-patient cognate KIR ligand combination and antithymocyte globulin preadministration are critical factors in outcome of HLA-C-KIR ligand-mismatched T cell-replete unrelated bone marrow transplantation.
Yabe T; Matsuo K; Hirayasu K; Kashiwase K; Kawamura-Ishii S; Tanaka H; Ogawa A; Takanashi M; Satake M; Nakajima K; Tokunaga K; Inoko H; Saji H; Ogawa S; Juji T; Sasazuki T; Kodera Y; Morishima Y;
Biol Blood Marrow Transplant; 2008 Jan; 14(1):75-87. PubMed ID: 18158964
[TBL] [Abstract][Full Text] [Related]
15. Activating KIR genes are associated with CMV reactivation and survival after non-T-cell depleted HLA-identical sibling bone marrow transplantation for malignant disorders.
Chen C; Busson M; Rocha V; Appert ML; Lepage V; Dulphy N; Haas P; Socié G; Toubert A; Charron D; Loiseau P
Bone Marrow Transplant; 2006 Sep; 38(6):437-44. PubMed ID: 16892071
[TBL] [Abstract][Full Text] [Related]
16. The effect of KIR ligand incompatibility on the outcome of unrelated donor transplantation: a report from the center for international blood and marrow transplant research, the European blood and marrow transplant registry, and the Dutch registry.
Farag SS; Bacigalupo A; Eapen M; Hurley C; Dupont B; Caligiuri MA; Boudreau C; Nelson G; Oudshoorn M; van Rood J; Velardi A; Maiers M; Setterholm M; Confer D; Posch PE; Anasetti C; Kamani N; Miller JS; Weisdorf D; Davies SM;
Biol Blood Marrow Transplant; 2006 Aug; 12(8):876-84. PubMed ID: 16864058
[TBL] [Abstract][Full Text] [Related]
17. Reconstitution of natural killer cell receptor repertoires after unmanipulated HLA-mismatched/haploidentical blood and marrow transplantation: analyses of CD94:NKG2A and killer immunoglobulin-like receptor expression and their associations with clinical outcome.
Zhao XY; Huang XJ; Liu KY; Xu LP; Liu DH
Biol Blood Marrow Transplant; 2007 Jun; 13(6):734-44. PubMed ID: 17531784
[TBL] [Abstract][Full Text] [Related]
18. Detrimental effect of natural killer cell alloreactivity in T-replete hematopoietic cell transplantation (HCT) for leukemia patients.
Sun JY; Dagis A; Gaidulis L; Miller MM; Rodriguez R; Parker P; Nademanee A; Falk P; Rosenthal J; Forman SJ; Senitzer D
Biol Blood Marrow Transplant; 2007 Feb; 13(2):197-205. PubMed ID: 17241925
[TBL] [Abstract][Full Text] [Related]
19. Influence of killer immunoglobulin-like receptor/HLA ligand matching on achievement of T-cell complete donor chimerism in related donor nonmyeloablative allogeneic hematopoietic stem cell transplantation.
Sobecks RM; Ball EJ; Askar M; Theil KS; Rybicki LA; Thomas D; Brown S; Kalaycio M; Andresen S; Pohlman B; Dean R; Sweetenham J; Macklis R; Bernhard L; Cherni K; Copelan E; Maciejewski JP; Bolwell BJ
Bone Marrow Transplant; 2008 Apr; 41(8):709-14. PubMed ID: 18195688
[TBL] [Abstract][Full Text] [Related]
20. KIR gene mismatching and KIR/C ligands in liver transplantation: consequences for short-term liver allograft injury.
Legaz I; López-Álvarez MR; Campillo JA; Moya-Quiles MR; Bolarín JM; de la Peña J; Salgado G; Gimeno L; García-Alonso AM; Muro M; Miras M; Alonso C; Álvarez-López MR; Minguela A
Transplantation; 2013 Apr; 95(8):1037-44. PubMed ID: 23478359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
